Cargando…
The epigenome as a putative target for skin repair: the HDAC inhibitor Trichostatin A modulates myeloid progenitor plasticity and behavior and improves wound healing
BACKGROUND: The molecular pathways that drive bone marrow myeloid progenitors (BMMP) development are very well understood and include a tight controlled multi-stage gene hierarch. Monocytes are versatile cells that display remarkable plasticity and may give rise to specific subsets of macrophages to...
Autores principales: | Cabanel, Mariana, da Costa, Thayse Pinheiro, EL-Cheikh, Marcia Cury, Carneiro, Katia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668089/ https://www.ncbi.nlm.nih.gov/pubmed/31366356 http://dx.doi.org/10.1186/s12967-019-1998-9 |
Ejemplares similares
-
Epigenetic Therapy as a Putative Molecular Target to Modulate B Cell Biology and Behavior in the Context of Immunological Disorders
por: da Costa, Thayse Pinheiro, et al.
Publicado: (2020) -
Differential response of cancer cells to HDAC inhibitors trichostatin A and depsipeptide
por: Chang, J, et al.
Publicado: (2012) -
HDAC inhibitor Trichostatin A suppresses adipogenesis in 3T3-L1 preadipocytes
por: Lv, Xin, et al.
Publicado: (2021) -
Galectin-3, histone deacetylases, and Hedgehog signaling: Possible convergent targets in schistosomiasis-induced liver fibrosis
por: de Oliveira, Felipe Leite, et al.
Publicado: (2017) -
Hdac3 deletion in myeloid progenitor cells enhances bone healing in females and limits osteoclast fusion via Pmepa1
por: Molstad, David H. H., et al.
Publicado: (2020)